Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Carreras MJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Laia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, Ana Callejo-Pérez, Eva Muñoz-Couselo, Carolina Ortiz-Velez, Nely Díaz-Mejía, Ana Barreira-Díaz, María José Carreras, Anna Farriols, María Buti, Mar Riveiro-Barciela
Publikováno v:
Scientia
Background and AimsImmunotherapy with immune checkpoint inhibitors (ICIs) is a pillar of many advanced tumors. However, there is scarce data concerning the rate of viral hepatitis screening in this population or the risk of viral reactivation.Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2e0b54ddec6fb6a71bbfd6fe25fbade
https://doi.org/10.3389/fmed.2022.916213
https://doi.org/10.3389/fmed.2022.916213
Autor:
Paula Gubern, Luisa Roade, Maria Buti, Francesc Bosch, María José Carreras, Anna Farriols, Rafael Esteban, Pau Abrisqueta, Mar Riveiro-Barciela
Publikováno v:
Scientific Reports
Scientia
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientia
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Hepatitis B; Hepatitis C Hepatitis B; Hepatitis C Hepatitis B; Hepatitis C Treatment of haematological disorders in patients with chronic hepatitis B or resolved infection (anti-HBc-positive) is associated with a risk of hepatitis B reactivation. Mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ba573581add5b28e9c3058d3122ba4
https://doi.org/10.1038/s41598-020-59476-4
https://doi.org/10.1038/s41598-020-59476-4
Autor:
Carreras MJ; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Renedo-Miró B; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Valdivia C; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Tomás-Guillén E; Asserta Global Healthcare Solutions, Sant Quirze del Vallés, E-08192 Barcelona, Spain., Farriols A; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Mañós L; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Vidal J; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Alcalde M; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., De la Paz I; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Jiménez-Lozano I; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Palacio-Lacambra ME; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Sabaté N; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Felip E; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), E-08035 Barcelona, Spain., Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), E-08035 Barcelona, Spain., Garau M; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Gorgas MQ; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Monterde J; Asserta Global Healthcare Solutions, Sant Quirze del Vallés, E-08192 Barcelona, Spain., Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), E-08035 Barcelona, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Apr 17; Vol. 16 (8). Date of Electronic Publication: 2024 Apr 17.
Autor:
García-Díaz HC; Department of Pharmacy Service, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Eremiev S; Medical Oncology Service, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Gómez-Alonso J; Department of Pharmacy Service, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Veas Rodriguez J; Department of Oncology, Hospital Arnau de Vilanova de Lleida, Lleida, Spain., Farriols A; Department of Pharmacy Service, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Carreras MJ; Department of Pharmacy Service, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Serrano C; Medical Oncology Service, Vall d'Hebron Hospital Universitari, Barcelona, Spain.
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Apr; Vol. 30 (3), pp. 576-583. Date of Electronic Publication: 2024 Jan 22.
Autor:
Carreras MJ; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Tomás-Guillén E; Asserta Global Healthcare Solutions, Sant Quirze del Vallés, E-08192 Barcelona, Spain., Farriols A; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Renedo-Miró B; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Valdivia C; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Vidal J; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), E-08035 Barcelona, Spain., Carles J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), E-08035 Barcelona, Spain., Felip E; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), E-08035 Barcelona, Spain., Gorgas MQ; Pharmacy Department, Vall d'Hebron University Hospital, E-08035 Barcelona, Spain., Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), E-08035 Barcelona, Spain., Monterde J; Asserta Global Healthcare Solutions, Sant Quirze del Vallés, E-08192 Barcelona, Spain.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Aug 30; Vol. 30 (9), pp. 7984-8004. Date of Electronic Publication: 2023 Aug 30.
Autor:
Aceituno L; Liver Unit, Hospital Vall d'Hebrón, Barcelona, Spain., Bañares J; Liver Unit, Hospital Vall d'Hebrón, Barcelona, Spain., Ruiz-Ortega L; Liver Unit, Hospital Vall d'Hebrón, Barcelona, Spain., Callejo-Pérez A; Oncology Department, Instituto de Oncología Vall d'Hebron (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Muñoz-Couselo E; Oncology Department, Instituto de Oncología Vall d'Hebron (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Ortiz-Velez C; Oncology Department, Instituto de Oncología Vall d'Hebron (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Díaz-Mejía N; Oncology Department, Instituto de Oncología Vall d'Hebron (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Barreira-Díaz A; Liver Unit, Hospital Vall d'Hebrón, Barcelona, Spain., Carreras MJ; Pharmacy Department, Vall d'Hebron Hospital, Barcelona, Spain., Farriols A; Pharmacy Department, Vall d'Hebron Hospital, Barcelona, Spain., Buti M; Liver Unit, Hospital Vall d'Hebrón, Barcelona, Spain.; Centro de Investigaciones Biomédicas de la Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain., Riveiro-Barciela M; Liver Unit, Hospital Vall d'Hebrón, Barcelona, Spain.; Centro de Investigaciones Biomédicas de la Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2022 Jul 15; Vol. 9, pp. 916213. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022).
Autor:
García-Carro C; Nephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain., Bolufer M; Nephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain., Bury R; Nephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain., Castañeda Z; Nephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain., Muñoz E; Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Felip E; Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Lorente D; Urology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain., Carreras MJ; Pharmacy Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain., Gabaldon A; Pathology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain., Agraz I; Nephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain., Serón D; Nephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain., Soler MJ; Nephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain.
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2022 Apr 25; Vol. 37 (5), pp. 887-894.